Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine vs ropivacaine for rhomboid intercostal and subserratus plane block in VATS lung resection
ChiCTR2500107186Phase 4Recruiting
- Sponsor
- Tangdu Hospital
- Start
- Aug 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial in postoperative pain comparing liposomal bupivacaine group with ropivacaine group (2 arms). Primary endpoint: The incidence of pain two days after postoperation. Started Aug 2025; status: recruiting.
02
Drugs
liposomal bupivacaineropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500107186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107186.